Clinical Trial Update: Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cyproheptadine hydrochloride with nutritional supplementation in weight-loss associated cancer in young patients was terminated and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Leukemia
• Lymphoma
• Malnutrition
• Myelodysplastic Syndromes

Drugs mentioned

• Cyproheptadine hydrochloride (cyproheptadine)
• Nutritional supplementation

Snippet

Sponsor: University of South Florida | Conditions: Leukemia, Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2014-03-04